Enhanced analytic methodology enables postmortem diagnosis of hereditary AApoAI amyloidosis [0.03%]
增强的分析方法可使遗传性AApoAI淀粉样变性的尸检诊断成为可能
Jeanne L Theis,Linda Hasadsri,Surendra Dasari et al.
Jeanne L Theis et al.
Right ventricular-pulmonary arterial coupling and outcomes in cardiac amyloidosis: systematic review and meta-analysis [0.03%]
心脏淀粉样变性患者右心室-肺动脉耦合与预后之间的关系：系统评价和 Meta 分析
Panagiotis Theofilis,Evangelos Oikonomou,Paschalis Karakasis et al.
Panagiotis Theofilis et al.
A novel transthyretin variant p.Val114Glu (Val94Glu) in an Italian patient with mixed phenotype hereditary transthyretin amyloidosis [0.03%]
意大利遗传性转甲状腺素蛋白淀粉样变患者中发现新型转甲状腺素蛋白变异体p.Val114Glu（Val94Glu）
Francesca Vitali,Mario Nuvolone,Angela Romano et al.
Francesca Vitali et al.
Men and women differ with regard to the prevalence, phenotype, and prognosis of wild-type transthyretin amyloid cardiomyopathy [0.03%]
性别差异对野生型血清淀粉样P蛋白缺乏症心肌病的流行病学、临床表型及预后的影响
Amira Zaroui,Charlotte Lafont,Mounira Kharoubi et al.
Amira Zaroui et al.
Background: We explored sex differences in wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) and determined survival and prognostic factors. Meth...
Prognostic impact of cardiac resynchronization therapy in wild-type transthyretin amyloid cardiomyopathy [0.03%]
野生型甲状腺素转运蛋白淀粉样变性心肌病的心脏再同步治疗预后的影响
Ojasav Sehrawat,Konstantinos C Siontis,Nicholas Tan et al.
Ojasav Sehrawat et al.
Unmasking the silent culprit: the elusive phenotypes of hereditary β2-microglobulin amyloidosis [0.03%]
拨开沉默元凶的面具——遗传性β2微球蛋白淀粉样变性的多样临床表现
Eduardo Boiteux Uchôa Cavalcanti,Savana Camilla de Lima Santos,Heveline Becker de Moura et al.
Eduardo Boiteux Uchôa Cavalcanti et al.
Early cardiovascular autonomic failure in ATTRv predicts poor prognosis and may respond to disease-modifying therapy [0.03%]
早期心血管自主神经功能障碍可预测ATTRv预后不良，并可能对疾病修饰治疗产生反应
Laura Sander,Giacomo Chiaro,Domenico Abelardo et al.
Laura Sander et al.
Background: Hereditary transthyretin amyloidosis (ATTRv) is a life-threatening, but treatable disease presenting with autonomic dysfunction. This study investigates the progression of autonomic failure, response to treatm...